[Application of Rapid HE Staining in Cytological Rapid On-site Evaluation of Peripheral Lung Cancer Needle Biopsy].

CT-guided lung biopsy Cytological rapid on-site evaluation Lung neoplasms Peripheral lung cancer Rapid HE staining

Journal

Zhongguo fei ai za zhi = Chinese journal of lung cancer
ISSN: 1999-6187
Titre abrégé: Zhongguo Fei Ai Za Zhi
Pays: China
ID NLM: 101126433

Informations de publication

Date de publication:
20 Aug 2023
Historique:
medline: 6 11 2023
pubmed: 27 9 2023
entrez: 26 9 2023
Statut: ppublish

Résumé

Rapid on-site evaluation (ROSE) is a technique used for simultaneous evaluation of biopsy specimens through rapid cytology staining. Diff-Quik (DQ) staining is the most commonly employed method for cytological rapid on-site evaluation (C-ROSE). However, the utilization of DQ staining for on-site cytological interpretation remains uncommon among pathologists in China, posing challenges to the implementation of C-ROSE. This study aims to assess the application of rapid hematoxylin-eosin (HE) staining and DQ staining for C-ROSE during percutaneous needle biopsy of peripheral lung cancer and evaluate the value of rapid HE staining in C-ROSE. Computed tomography (CT)-guided lung biopsies were conducted on 300 patients diagnosed with peripheral lung cancer. The patients were randomly assigned to two groups for C-ROSE using either rapid HE staining or DQ staining, and subsequently the two methods were compared and evaluated. The concordance rate between C-ROSE and histopathological diagnosis was 96.7%. The median staining time for rapid HE staining was 160 s, while that for DQ staining was 120 s, representing a significant difference between the two groups (P<0.001). However, there were no significant differences observed in terms of total biopsy time, concordance rate with histopathology, cytology specimen peeling rate, and incidence of serious adverse reactions between the two groups (P>0.05). Both staining methods comply with C-ROSE criteria in the biopsy setting of peripheral lung cancer. Rapid HE staining is more aligned with domestic clinical requirements and holds potential for further promotion and adoption in C-ROSE. 【中文题目:快速HE染色在周围型肺癌穿刺活检
快速现场细胞学评价中的应用】 【中文摘要:背景与目的 快速现场评价(rapid on-site evaluation, ROSE)是在活检术中同步实施的标本快速细胞学染色和评价技术。迪夫(Diff-Quik, DQ)染色是快速现场细胞学评价(cytological ROSE, C-ROSE)最常用的染色方法,但国内大部分病理医生不使用DQ染色进行现场细胞学判读,因此难以开展C-ROSE。本研究拟在周围型肺癌穿刺活检过程中分别使用快速苏木素-伊红(hematoxylin-eosin, HE)染色和DQ染色进行C-ROSE,评估快速HE染色在C-ROSE中的应用价值。方法 对300例术前拟诊周围型肺癌患者实施胸部计算机断层扫描(computed tomography, CT)引导肺活检,随机分成两组且分别使用快速HE染色和DQ染色,进行C-ROSE判读,并对两种染色方法进行比较和评价。结果 C-ROSE与组织病理诊断符合率为96.7%。快速HE染色的中位时间为160 s,而DQ染色为120 s,两组存在统计学差异(P<0.001)。但两组的肺活检时间、组织病理符合率、细胞学标本脱片率和严重不良反应发生率均无统计学差异(P>0.05)。结论 在周围型肺癌活检过程中,两种染色方法均能满足C-ROSE要求,快速HE染色可应用于C-ROSE,且更符合国内临床需求,具有潜在的推广价值。
】 【中文关键词:肺肿瘤;周围型肺癌;CT引导肺活检;快速现场细胞学评价;快速HE染色】.

Sections du résumé

BACKGROUND BACKGROUND
Rapid on-site evaluation (ROSE) is a technique used for simultaneous evaluation of biopsy specimens through rapid cytology staining. Diff-Quik (DQ) staining is the most commonly employed method for cytological rapid on-site evaluation (C-ROSE). However, the utilization of DQ staining for on-site cytological interpretation remains uncommon among pathologists in China, posing challenges to the implementation of C-ROSE. This study aims to assess the application of rapid hematoxylin-eosin (HE) staining and DQ staining for C-ROSE during percutaneous needle biopsy of peripheral lung cancer and evaluate the value of rapid HE staining in C-ROSE.
METHODS METHODS
Computed tomography (CT)-guided lung biopsies were conducted on 300 patients diagnosed with peripheral lung cancer. The patients were randomly assigned to two groups for C-ROSE using either rapid HE staining or DQ staining, and subsequently the two methods were compared and evaluated.
RESULTS RESULTS
The concordance rate between C-ROSE and histopathological diagnosis was 96.7%. The median staining time for rapid HE staining was 160 s, while that for DQ staining was 120 s, representing a significant difference between the two groups (P<0.001). However, there were no significant differences observed in terms of total biopsy time, concordance rate with histopathology, cytology specimen peeling rate, and incidence of serious adverse reactions between the two groups (P>0.05).
CONCLUSIONS CONCLUSIONS
Both staining methods comply with C-ROSE criteria in the biopsy setting of peripheral lung cancer. Rapid HE staining is more aligned with domestic clinical requirements and holds potential for further promotion and adoption in C-ROSE.
【中文题目:快速HE染色在周围型肺癌穿刺活检
快速现场细胞学评价中的应用】 【中文摘要:背景与目的 快速现场评价(rapid on-site evaluation, ROSE)是在活检术中同步实施的标本快速细胞学染色和评价技术。迪夫(Diff-Quik, DQ)染色是快速现场细胞学评价(cytological ROSE, C-ROSE)最常用的染色方法,但国内大部分病理医生不使用DQ染色进行现场细胞学判读,因此难以开展C-ROSE。本研究拟在周围型肺癌穿刺活检过程中分别使用快速苏木素-伊红(hematoxylin-eosin, HE)染色和DQ染色进行C-ROSE,评估快速HE染色在C-ROSE中的应用价值。方法 对300例术前拟诊周围型肺癌患者实施胸部计算机断层扫描(computed tomography, CT)引导肺活检,随机分成两组且分别使用快速HE染色和DQ染色,进行C-ROSE判读,并对两种染色方法进行比较和评价。结果 C-ROSE与组织病理诊断符合率为96.7%。快速HE染色的中位时间为160 s,而DQ染色为120 s,两组存在统计学差异(P<0.001)。但两组的肺活检时间、组织病理符合率、细胞学标本脱片率和严重不良反应发生率均无统计学差异(P>0.05)。结论 在周围型肺癌活检过程中,两种染色方法均能满足C-ROSE要求,快速HE染色可应用于C-ROSE,且更符合国内临床需求,具有潜在的推广价值。
】 【中文关键词:肺肿瘤;周围型肺癌;CT引导肺活检;快速现场细胞学评价;快速HE染色】.

Autres résumés

Type: Publisher (chi)
【中文题目:快速HE染色在周围型肺癌穿刺活检
快速现场细胞学评价中的应用】 【中文摘要:背景与目的 快速现场评价(rapid on-site evaluation, ROSE)是在活检术中同步实施的标本快速细胞学染色和评价技术。迪夫(Diff-Quik, DQ)染色是快速现场细胞学评价(cytological ROSE, C-ROSE)最常用的染色方法,但国内大部分病理医生不使用DQ染色进行现场细胞学判读,因此难以开展C-ROSE。本研究拟在周围型肺癌穿刺活检过程中分别使用快速苏木素-伊红(hematoxylin-eosin, HE)染色和DQ染色进行C-ROSE,评估快速HE染色在C-ROSE中的应用价值。方法 对300例术前拟诊周围型肺癌患者实施胸部计算机断层扫描(computed tomography, CT)引导肺活检,随机分成两组且分别使用快速HE染色和DQ染色,进行C-ROSE判读,并对两种染色方法进行比较和评价。结果 C-ROSE与组织病理诊断符合率为96.7%。快速HE染色的中位时间为160 s,而DQ染色为120 s,两组存在统计学差异(P<0.001)。但两组的肺活检时间、组织病理符合率、细胞学标本脱片率和严重不良反应发生率均无统计学差异(P>0.05)。结论 在周围型肺癌活检过程中,两种染色方法均能满足C-ROSE要求,快速HE染色可应用于C-ROSE,且更符合国内临床需求,具有潜在的推广价值。
】 【中文关键词:肺肿瘤;周围型肺癌;CT引导肺活检;快速现场细胞学评价;快速HE染色】.

Identifiants

pubmed: 37752537
doi: 10.3779/j.issn.1009-3419.2023.101.24
pmc: PMC10558760
doi:

Substances chimiques

Eosine Yellowish-(YS) TDQ283MPCW

Types de publication

Randomized Controlled Trial English Abstract Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

572-578

Références

Endosc Ultrasound. 2017 Jul-Aug;6(4):219-230
pubmed: 28820144
Clin Respir J. 2020 May;14(5):447-452
pubmed: 31916391
Zhonghua Zhong Liu Za Zhi. 2023 Jul 23;45(7):539-574
pubmed: 37460438
Chest. 2018 Apr;153(4):929-938
pubmed: 29154972
Korean J Radiol. 2019 Feb;20(2):323-331
pubmed: 30672172
Zhongguo Fei Ai Za Zhi. 2021 May 20;24(5):331-337
pubmed: 34034456
Acta Cytol. 2018;62(4):244-252
pubmed: 29874653
Diagn Cytopathol. 2019 Jan;47(1):15-19
pubmed: 29575752
Cytopathology. 2016 Oct;27(5):344-50
pubmed: 27146559
J Cytol. 2015 Oct-Dec;32(4):230-3
pubmed: 26811569
Cytopathology. 2022 Jul;33(4):439-444
pubmed: 35362154
J Natl Compr Canc Netw. 2022 May;20(5):497-530
pubmed: 35545176
Oncologist. 2019 Dec;24(12):1570-1576
pubmed: 31152082
Eur Radiol. 2017 Jan;27(1):138-148
pubmed: 27108299
Chest. 2013 May;143(5 Suppl):e142S-e165S
pubmed: 23649436
Zhongguo Fei Ai Za Zhi. 2018 Nov 20;21(11):833-840
pubmed: 30454545

Auteurs

Jian He (J)

Department of Pulmonary and Critical Care Medicine, Anning First People's Hospital, Kunming 650300, China.

Guilan Xia (G)

Department of Pathology, Anning First People's Hospital, Kunming 650300, China.

Shiping Wang (S)

Imaging Medical Center, Anning First People's Hospital, Kunming 650300, China.

Kun Chen (K)

Department of Laboratory Medicine, Baoshan District of Huashan Hospital, Fudan University, Shanghai 200040, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH